About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Intravenous to Subcutaneous Drug Repositioning Market Size, Growth, 2031

Intravenous to Subcutaneous Drug Repositioning Market

Intravenous to Subcutaneous Drug Repositioning Market Size, Share & Trends Analysis Report By Product (Devices, Drugs), By Therapeutic (Cardiology, Oncology, Pulmonary arterial hypertension, Hematology, Others), By End-user (Hospitals and clinics, Research facilities, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI681DR
Study Period 2020-2032 CAGR 4.6%
Historical Period 2020-2022 Forecast Period 2024-2032
Base Year 2023 Base Year Market Size USD XX Billion
Forecast Year 2032 Forecast Year Market Size USD XX Billion
Largest Market North America Fastest Growing Market South America
Show More
Buy Now
File Formats
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Intravenous to Subcutaneous Drug Repositioning Market, By Product (2021-2031)
    1. Devices
      1. Wearable SC injectors
      2. Wearable SC infusers
    2. Drugs
      1. Cancer drugs
      2. Blood factors
      3. Immunoglobulin G
      4. Antibiotics
      5. Remodulin
      6. Others
  2. Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic (2021-2031)
    1. Cardiology
    2. Oncology
    3. Pulmonary arterial hypertension
    4. Hematology
    5. Others
  3. Intravenous to Subcutaneous Drug Repositioning Market, By End-user (2021-2031)
    1. Hospitals and clinics
    2. Research facilities
    3. Others
    1. North America
      1. North America Intravenous to Subcutaneous Drug Repositioning Market, By Product
        1. Devices
          1. Wearable SC injectors
            1. Wearable SC infusers
            2. Drugs
              1. Cancer drugs
                1. Blood factors
                  1. Immunoglobulin G
                    1. Antibiotics
                      1. Remodulin
                        1. Others
                      2. North America Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                        1. Cardiology
                          1. Oncology
                            1. Pulmonary arterial hypertension
                              1. Hematology
                                1. Others
                                2. North America Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                  1. Hospitals and clinics
                                    1. Research facilities
                                      1. Others
                                      2. U.S.
                                        1. U.S. Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                          1. Devices
                                            1. Wearable SC injectors
                                              1. Wearable SC infusers
                                              2. Drugs
                                                1. Cancer drugs
                                                  1. Blood factors
                                                    1. Immunoglobulin G
                                                      1. Antibiotics
                                                        1. Remodulin
                                                          1. Others
                                                        2. U.S. Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                          1. Cardiology
                                                            1. Oncology
                                                              1. Pulmonary arterial hypertension
                                                                1. Hematology
                                                                  1. Others
                                                                  2. U.S. Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                    1. Hospitals and clinics
                                                                      1. Research facilities
                                                                        1. Others
                                                                      2. Canada
                                                                    2. Europe
                                                                      1. Europe Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                        1. Devices
                                                                          1. Wearable SC injectors
                                                                            1. Wearable SC infusers
                                                                            2. Drugs
                                                                              1. Cancer drugs
                                                                                1. Blood factors
                                                                                  1. Immunoglobulin G
                                                                                    1. Antibiotics
                                                                                      1. Remodulin
                                                                                        1. Others
                                                                                      2. Europe Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                        1. Cardiology
                                                                                          1. Oncology
                                                                                            1. Pulmonary arterial hypertension
                                                                                              1. Hematology
                                                                                                1. Others
                                                                                                2. Europe Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                  1. Hospitals and clinics
                                                                                                    1. Research facilities
                                                                                                      1. Others
                                                                                                      2. U.K.
                                                                                                        1. U.K. Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                          1. Devices
                                                                                                            1. Wearable SC injectors
                                                                                                              1. Wearable SC infusers
                                                                                                              2. Drugs
                                                                                                                1. Cancer drugs
                                                                                                                  1. Blood factors
                                                                                                                    1. Immunoglobulin G
                                                                                                                      1. Antibiotics
                                                                                                                        1. Remodulin
                                                                                                                          1. Others
                                                                                                                        2. U.K. Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                          1. Cardiology
                                                                                                                            1. Oncology
                                                                                                                              1. Pulmonary arterial hypertension
                                                                                                                                1. Hematology
                                                                                                                                  1. Others
                                                                                                                                  2. U.K. Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                    1. Hospitals and clinics
                                                                                                                                      1. Research facilities
                                                                                                                                        1. Others
                                                                                                                                      2. Germany
                                                                                                                                      3. France
                                                                                                                                      4. Spain
                                                                                                                                      5. Italy
                                                                                                                                      6. Russia
                                                                                                                                      7. Nordic
                                                                                                                                      8. Benelux
                                                                                                                                      9. Rest of Europe
                                                                                                                                    2. APAC
                                                                                                                                      1. APAC Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                        1. Devices
                                                                                                                                          1. Wearable SC injectors
                                                                                                                                            1. Wearable SC infusers
                                                                                                                                            2. Drugs
                                                                                                                                              1. Cancer drugs
                                                                                                                                                1. Blood factors
                                                                                                                                                  1. Immunoglobulin G
                                                                                                                                                    1. Antibiotics
                                                                                                                                                      1. Remodulin
                                                                                                                                                        1. Others
                                                                                                                                                      2. APAC Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                        1. Cardiology
                                                                                                                                                          1. Oncology
                                                                                                                                                            1. Pulmonary arterial hypertension
                                                                                                                                                              1. Hematology
                                                                                                                                                                1. Others
                                                                                                                                                                2. APAC Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                  1. Hospitals and clinics
                                                                                                                                                                    1. Research facilities
                                                                                                                                                                      1. Others
                                                                                                                                                                      2. China
                                                                                                                                                                        1. China Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                          1. Devices
                                                                                                                                                                            1. Wearable SC injectors
                                                                                                                                                                              1. Wearable SC infusers
                                                                                                                                                                              2. Drugs
                                                                                                                                                                                1. Cancer drugs
                                                                                                                                                                                  1. Blood factors
                                                                                                                                                                                    1. Immunoglobulin G
                                                                                                                                                                                      1. Antibiotics
                                                                                                                                                                                        1. Remodulin
                                                                                                                                                                                          1. Others
                                                                                                                                                                                        2. China Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                                                          1. Cardiology
                                                                                                                                                                                            1. Oncology
                                                                                                                                                                                              1. Pulmonary arterial hypertension
                                                                                                                                                                                                1. Hematology
                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                  2. China Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                                                    1. Hospitals and clinics
                                                                                                                                                                                                      1. Research facilities
                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                      2. Korea
                                                                                                                                                                                                      3. Japan
                                                                                                                                                                                                      4. India
                                                                                                                                                                                                      5. Australia
                                                                                                                                                                                                      6. Taiwan
                                                                                                                                                                                                      7. South East Asia
                                                                                                                                                                                                      8. Rest of Asia-Pacific
                                                                                                                                                                                                    2. Middle East and Africa
                                                                                                                                                                                                      1. Middle East and Africa Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                                                        1. Devices
                                                                                                                                                                                                          1. Wearable SC injectors
                                                                                                                                                                                                            1. Wearable SC infusers
                                                                                                                                                                                                            2. Drugs
                                                                                                                                                                                                              1. Cancer drugs
                                                                                                                                                                                                                1. Blood factors
                                                                                                                                                                                                                  1. Immunoglobulin G
                                                                                                                                                                                                                    1. Antibiotics
                                                                                                                                                                                                                      1. Remodulin
                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                      2. Middle East and Africa Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                                                                                        1. Cardiology
                                                                                                                                                                                                                          1. Oncology
                                                                                                                                                                                                                            1. Pulmonary arterial hypertension
                                                                                                                                                                                                                              1. Hematology
                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                2. Middle East and Africa Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                                                                                  1. Hospitals and clinics
                                                                                                                                                                                                                                    1. Research facilities
                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                      2. UAE
                                                                                                                                                                                                                                        1. UAE Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                                                                                          1. Devices
                                                                                                                                                                                                                                            1. Wearable SC injectors
                                                                                                                                                                                                                                              1. Wearable SC infusers
                                                                                                                                                                                                                                              2. Drugs
                                                                                                                                                                                                                                                1. Cancer drugs
                                                                                                                                                                                                                                                  1. Blood factors
                                                                                                                                                                                                                                                    1. Immunoglobulin G
                                                                                                                                                                                                                                                      1. Antibiotics
                                                                                                                                                                                                                                                        1. Remodulin
                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                        2. UAE Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                                                                                                                          1. Cardiology
                                                                                                                                                                                                                                                            1. Oncology
                                                                                                                                                                                                                                                              1. Pulmonary arterial hypertension
                                                                                                                                                                                                                                                                1. Hematology
                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                  2. UAE Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                                                                                                                    1. Hospitals and clinics
                                                                                                                                                                                                                                                                      1. Research facilities
                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                      1. LATAM Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                                                                                                                        1. Devices
                                                                                                                                                                                                                                                                          1. Wearable SC injectors
                                                                                                                                                                                                                                                                            1. Wearable SC infusers
                                                                                                                                                                                                                                                                            2. Drugs
                                                                                                                                                                                                                                                                              1. Cancer drugs
                                                                                                                                                                                                                                                                                1. Blood factors
                                                                                                                                                                                                                                                                                  1. Immunoglobulin G
                                                                                                                                                                                                                                                                                    1. Antibiotics
                                                                                                                                                                                                                                                                                      1. Remodulin
                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                      2. LATAM Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                                                                                                                                                        1. Cardiology
                                                                                                                                                                                                                                                                                          1. Oncology
                                                                                                                                                                                                                                                                                            1. Pulmonary arterial hypertension
                                                                                                                                                                                                                                                                                              1. Hematology
                                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                                2. LATAM Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                                                                                                                                                  1. Hospitals and clinics
                                                                                                                                                                                                                                                                                                    1. Research facilities
                                                                                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                                                                                      2. Brazil
                                                                                                                                                                                                                                                                                                        1. Brazil Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                                                                                                                                                          1. Devices
                                                                                                                                                                                                                                                                                                            1. Wearable SC injectors
                                                                                                                                                                                                                                                                                                              1. Wearable SC infusers
                                                                                                                                                                                                                                                                                                              2. Drugs
                                                                                                                                                                                                                                                                                                                1. Cancer drugs
                                                                                                                                                                                                                                                                                                                  1. Blood factors
                                                                                                                                                                                                                                                                                                                    1. Immunoglobulin G
                                                                                                                                                                                                                                                                                                                      1. Antibiotics
                                                                                                                                                                                                                                                                                                                        1. Remodulin
                                                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                                                        2. Brazil Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                                                                                                                                                                                          1. Cardiology
                                                                                                                                                                                                                                                                                                                            1. Oncology
                                                                                                                                                                                                                                                                                                                              1. Pulmonary arterial hypertension
                                                                                                                                                                                                                                                                                                                                1. Hematology
                                                                                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                                                                                  2. Brazil Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                                                                                                                                                                                    1. Hospitals and clinics
                                                                                                                                                                                                                                                                                                                                      1. Research facilities
                                                                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                                                                      2. Mexico
                                                                                                                                                                                                                                                                                                                                      3. Argentina
                                                                                                                                                                                                                                                                                                                                      4. Chile
                                                                                                                                                                                                                                                                                                                                      5. Colombia
                                                                                                                                                                                                                                                                                                                                      6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                  Related Reports

                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                  The global tool steel market size was valued at USD 5.07 billion in 2021. It is estimated to reach an expected value of USD 8.16 billion by 2030 at a CAGR of 5.3% during the forecast period (2022-2030).  Tool steels are from the carbon ste
                                                                                                                                                                                                                                                                                                                                  Buy Now
                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                  The global sleep apnea devices market size was valued at USD 4,584.90 million in 2022. It is expected to reach USD 9,405.63 million by 2031, growing at a CAGR of 8.3% during the forecast period (2023–2031). Sleep apnea is a sleeping disorder c
                                                                                                                                                                                                                                                                                                                                  Buy Now
                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                  The global fire sprinkler market size was valued at USD 12.49 Billion in 2021. It is expected to reach USD 22.26 Billion by 2030, growing at a CAGR of 7.49% during the forecast period (2022–2030). A fire sprinkler system is a straightforward y
                                                                                                                                                                                                                                                                                                                                  Buy Now
                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                  The global print on demand market was valued at USD 6.3 billion in 2022. It is projected to reach USD 45.6 billion by 2031, growing at a CAGR of 25.3% during the forecast period (2023–2031). E-commerce expansion and the growing trend of online
                                                                                                                                                                                                                                                                                                                                  Buy Now
                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                  The global platinum market size was valued at USD 7.72 billion in 2022 and is projected to reach USD 11.95 billion by 2031 at a CAGR of 5.13% from 2023 to 2031. Platinum is a crucial component in catalytic converters used to reduce harmful
                                                                                                                                                                                                                                                                                                                                  Buy Now

                                                                                                                                                                                                                                                                                                                                  Purchase Benefits

                                                                                                                                                                                                                                                                                                                                  • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                                                                  • Completely customizable scope
                                                                                                                                                                                                                                                                                                                                  • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                                                                  • Dedicated account manager
                                                                                                                                                                                                                                                                                                                                  • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                                                                  • Permission to print the report

                                                                                                                                                                                                                                                                                                                                  We are featured on :

                                                                                                                                                                                                                                                                                                                                  www.straitsresearch.com
                                                                                                                                                                                                                                                                                                                                  © Copyright . All rights Reserved.